Larvol Delta - Abata-Therapeutics-Receives-FDA-Fast-Track-Designation-for-ABA101-for-the-Treatment-of-Progressive-Multiple-Sclerosis

ABA-101 - Abata Therap

https://www.globenewswire.com/news-release/2024/08/22/2934105/0/en/Abata-Therapeutics-Receives-FDA-Fast-Track-Designation-for-ABA-101-for-the-Treatment-of-Progressive-Multiple-Sclerosis.html

Aug 22, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next